This is the authors' abstract. We don't add key points for this paper.
This account of the mechanisms of scleroderma highlights the genetic and molecular changes that cause the vascular changes and fibrosis in the disease. The role of autoantibodies, of which there are several in scleroderma, is unclear. The authors outline a stepwise process that begins with inflammation, reaches its zenith in fibrosis, and ends in atrophy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gabrielli et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: